Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CloseHER2 Home community pharmacy trastuzumab pathway study
ISRCTN15965214Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Feb 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 4, open-label trial of trastuzumab in breast cancer (2 arms), sponsored by University of Dundee. Primary endpoints: Completion of 4 cycles via Community Pharmacy Pathway and Process evaluation of the Community Pharmacy Pathway. Started Feb 2022; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN15965214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15965214.